Results 171 to 180 of about 106,775 (245)

Risk of peripheral vestibular disorders and hearing impairment among users of glucagon-like peptide-1 receptor agonists. [PDF]

Int J Med Sci
Huang JY, Lu YT, Hsin CH, Lo TS, Lee CY, Yang SF, Liao MY.   +6 more
europepmc   +1 more source

The Influence of Glucagon-like Peptide-1 Receptor Agonists on Outcomes Following Trigger Finger Release. [PDF]

J Hand Surg Glob Online
Dameron LS, Bank NC, Raghava N, Himmelberg S, Knoll GM.   +4 more
europepmc   +1 more source

Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov. [PDF]

Addict Behav Rep
Patil S, Jha N, Jha MK.
europepmc   +1 more source

Impact of glucagon-like peptide-1 receptor agonists on colonoscopy outcomes: a systematic review and meta-analysis. [PDF]

Clin Endosc
Abdulraheem A, Abujaber B, Ayers L, Afzal U, Qarkash D, Altork N, Al-Zureikat Q, Bashiri K, Almhanni G, Spyros P, Cho WK.   +10 more
europepmc   +1 more source

Impact of Glucagon-Like Peptide-1 Receptor Agonists on Knee Arthroplasty Outcomes. [PDF]

Indian J Orthop
Zaffar H, Imran MA, Rushd F.
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists in Chronic Kidney Disease: Mechanisms and Clinical Perspectives. [PDF]

Kidney Med
Meier M, Cummings J, Abdelsaid M, Feliciano J, Eusebe J, Stirn H, Coucha M.   +6 more
europepmc   +1 more source

Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use. [PDF]

Diabetes Obes Metab
Vilsbøll T, Stellfeld M, Aroda VR, Dandanell S, David JP, Kristiansen CTP, Rasmussen S, Roberts FL, Hegedüs L.   +8 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists for Arthritis and Osteoarthritis. [PDF]

Cureus
Nashwan AJ.
europepmc   +1 more source

Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet–induced Mouse Model

Huimin Xia, Yuqin Min, Yuhua Wang, Siyu Gao, Hailing Wang, Fuhua Yan, Ruixin Liu, Jiqiu Wang, Xuejiang Gu, Tingting Bo   +9 more
openalex   +1 more source

Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study. [PDF]

Health Aff Sch
Mattingly TJ, Duru EE, Conti RM.
europepmc   +1 more source